Acadia Pharmaceuticals (ACAD) Cash from Investing Activities (QoQ) (2010 - 2026)
Acadia Pharmaceuticals (ACAD) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Acadia Pharmaceuticals | 4.35 Bn | 3.50 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 218.64% |
| Dec 31, 2025 | 29.59% |
| Sep 30, 2025 | -83.29% |
| Jun 30, 2025 | 65.10% |
| Mar 31, 2025 | -201.55% |
| Dec 31, 2024 | 248.14% |
| Sep 30, 2024 | -46.74% |
| Jun 30, 2024 | -300.26% |
| Mar 31, 2024 | -3,945.82% |
| Dec 31, 2023 | -101.02% |
| Sep 30, 2023 | 117.56% |
| Jun 30, 2023 | -200.92% |
| Mar 31, 2023 | 1,184.73% |
| Dec 31, 2022 | -214.94% |
| Sep 30, 2022 | 127.67% |
| Jun 30, 2022 | -142.48% |
| Mar 31, 2022 | 83.57% |
| Dec 31, 2021 | 145.77% |
| Sep 30, 2021 | -808.47% |
| Jun 30, 2021 | -155.73% |